Seeing further.

THAT’S OUR TARGET

We’re advancing our RNA-based treatments so patients with cancer can enjoy the moments that matter.

Learn More

Transforming Immunity. Restoring Hope.

We’re committed to redefining the treatment of certain cancers and rare diseases.

Learn More

Scientists. Believers. People.

At Idera, we’re working hard to translate our nucleic acid science into life-changing medicines.

Discover Idera

The Latest

Keep up with what’s happening at Idera Pharmaceuticals.

News

Idera Pharmaceuticals To Present at the 2018 Wedbush PacGrow Healthcare Conference

EXTON, Pa. , Aug. 09, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a… Read more 

Idera Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Abstract accepted for 2018 European Society of Medical Oncology Annual Meeting  Cash runway into… Read more 

Idera Pharmaceuticals Announces One-for-Eight Reverse Stock Split

EXTON, Pa. , July 27, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a… Read more 

Learn More

Events

Idera Pharmaceuticals, Inc. Events

Idera Pharmaceuticals, Inc. Events… Read more 

Learn More